Рыночная капитализация Изменить Дата
Acadia Pharmaceuticals USD 3.57B 221M 2026-05
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amgen USD 189.89B 13.64B 2026-03
BioCryst Pharmaceuticals USD 1.66B 64M 2025-12
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 10.18B 683M 2026-05
Cytokinetics USD 9.16B 975M 2026-05
Daiichi Sankyo JPY 6.34T 62.51B 2025-12
Enanta Pharmaceuticals USD 122M 98M 2024-12
Esperion Therapeutics USD 885M 351M 2025-12
Gilead Sciences USD 167.39B 5.6B 2026-05
Incyte USD 21.73B 3B 2026-05
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
Karyopharm Therapeutics USD 956M 821M 2026-05
Novartis USD 232.75B 75B 2026-05
Pfizer USD 147.4B 6.42B 2026-05
PTC Therapeutics USD 4.94B 698M 2026-05
Roche Holding CHF 266.34B 55.46B 2025-12
Sarepta Therapeutics USD 2.16B 123M 2026-05
TG Therapeutics USD 6.48B 1.18B 2026-05
Ultragenyx Pharmaceutical USD 2.06B 1000K 2026-05
Vertex Pharmaceuticals USD 113.58B 1000K 2026-05
Xencor USD 795M 98M 2026-05